SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $417,805 | -33.4% | 120,405 | -10.8% | 0.00% | – |
Q2 2023 | $627,671 | -13.9% | 134,983 | -14.5% | 0.00% | – |
Q1 2023 | $729,212 | +747.9% | 157,838 | +913.4% | 0.00% | – |
Q3 2022 | $86,000 | -81.4% | 15,575 | -82.5% | 0.00% | – |
Q2 2022 | $463,000 | +31.2% | 88,751 | +106.9% | 0.00% | – |
Q1 2022 | $353,000 | -68.6% | 42,904 | -43.2% | 0.00% | – |
Q4 2021 | $1,124,000 | +102.5% | 75,516 | +157.0% | 0.00% | – |
Q3 2021 | $555,000 | -45.3% | 29,382 | -46.1% | 0.00% | – |
Q2 2021 | $1,014,000 | -54.8% | 54,522 | -44.7% | 0.00% | – |
Q1 2021 | $2,244,000 | -38.9% | 98,575 | -41.7% | 0.00% | – |
Q4 2020 | $3,672,000 | – | 169,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |